SinglePoint Inc. (OTC:SING) Eliminates Debt and Gains Additional $1m in Funding

SinglePoint, Inc. (OTC: SING) has raised more than $300,000 and has signed a Letter of Intent to secure additional funding of $1 million.

Today's update follows news of the Company's recent Letter of Intent to acquire a stake in Convectium, which created the world's first machine capable of filling cartridges or disposables en mass for wholesale distribution to cannabis dispensaries.

Alliance Growth Corp. (CSE:AGC) Assembles Top-Teir Growing Team

Alliance Growth Corp. executives announce that the Company has executed the founders agreement with a private Health Canada Licensed Producer Applicant based in Ontario, Canada.

The next step is a $25,000 first payment for the equity investment. The agreement will include long term plantlet supply contract and an off-take agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry 07/02/2017 14:30 PALM BEACH, Florida , February 7, 2017 /PRNewswire/ -- The injection of modern technology into the developing world of cannabis and legal medical marijuana is helping the industry climb to new heights and increase engagement with consumers, especially when it comes to cannabis patients in the medical facet of the industry.

Disruptive Technology: Here’s The Future $PKG $WEED $MYM $PTNYF

Ding Dong: Here’s Your Pot. In the world of new and disruptive technologies, there are a few ideas that just make a lot of sense to everyone. And sure enough, several have become overnight sensations creating unimaginable wealth (especially for early investors), while changing the landscape completely. The funny thing is, they often don’t rely on infrastructure or conventional business models at all.

Ex-Medical Marijuana Officials Charged for Illegal Shipment

BY KYLE POTTER ASSOCIATED PRESS

ST. PAUL, Minn. (AP) — Prosecutors in Minnesota filed felony charges Monday against two former officials from one of the state’s licensed medical marijuana manufacturers for allegedly shipping marijuana oil to a subsidiary facility in New York.

Crown Baus (OTC:CBCA) to Spend Upwards of $6m on Greenhouse Space

Crown Baus Capital Corp. (OTC:CBCA) is negotiating investment opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada.

Phase 1 for each one acre build-out will cost approximately $300,000 to $500,000 USD with full production capacity maxing out at approximately 33,000 sq. ft.

Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR

INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that on February 6, 2017 it had entered into a binding letter of intent (“LOI”) for an option to acquire 100% (the “Option”) of the outstanding shares of a Late Stage Applicant (the “OptionCo”) under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) from its current shareholders (the “Vendors”).

Invictus MD (CSE:IMH, OTC:IVITF) Aquires 150 acres to Increase Production

Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares of a late stage applicant ("OptionCo") from its current shareholders. OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres, which is expected to have production capacity of up to 6,000 kg per annum. OptionCo has already submitted plans for additional buildings on the Property including a 30,000 square foot facility.

QuikFlo (TSXV:QF) Moves into the US Marketplace

QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

The acquisitions include a 12,000 sq. ft. licensed medical marijuana cultivation/production facility and packaging center with over $1 million in medicinal sales in its first year of operation.  The second acquisition is of a start-up company that develops and markets hemp based and CBD infused products for sales nationwide. 

QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

By: Filing Services Canada via Filing Services Canada February 06, 2017 at 17:20 PM EST QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company. QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

Aphria (TSXV:APH) Graduates to the TSX

Aphria (TSXV:APH, OTC:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX.

Aphria Receives Conditional Approval to Graduate to the TSX

Tags APH , APHQF , Aphria , Leamington , Ontario , OTCQB , Press Release , Shareholders , TSX , TSX VENTURE , Vic Neufeld LEAMINGTON, Ontario, Feb. 6, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange and list its common shares on the TSX.

"Marapharm" Announces That its Subsidiary has Developed its Product Line for Oils and Edibles in Nevada

"Marapharm" Announces That its Subsidiary has Developed its Product Line for Oils and Edibles in Nevada KELOWNA, British Columbia , February Marapharm Ventures Inc., (OTCQB: MRPHF) is the sole owner of Econevada LLC, which is the holder of a provisional production license for lab tested oils and edible cannabis infused products which will be produced in Marapharm's facility. The facility is presently under construction in Apex Industrial Park, Las Vegas, Nevada .